Formulation and Drug Delivery

October 03, 2014

LABOCHIM SpA completes construction on multipurpose high-potent API plant in Milan.

October 02, 2014

Demand for new therapies and vaccines spotlights production challenges.

October 02, 2014

Weighing the pros and cons of hot-melt extrusion and spray drying.

October 02, 2014

Regulatory agencies in Europe are working to harmonize the marketing approval pathway of generic medicines.

October 02, 2014

Advances in solid and liquid formulation techniques are providing more options.

September 30, 2014

NIH seeks new therapeutic products to bolster the protective properties of vaccines.

September 26, 2014

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

September 25, 2014

USP expresses its support for a consensus-based global approach to the naming of biologics.

September 25, 2014

Formulation will utilize Catalent?s OSDrC OptiDose multicore drug-delivery platform.

September 23, 2014

CALIXAR and VirPath use new manufacturing techniques to create a vaccine for the pandemic flu, influenza A (H1N1), available in 2015.